Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,145	$ 4,299
Accounts receivable, net of allowance for credit losses of $107 and $111, respectively	4,546	5,511
Inventory	7,595	7,930
Other current assets	4,515	4,430
Total current assets	19,801	22,170
Property, plant and equipment, net	2,774	2,546
Goodwill	8,541	6,803
Other non-current assets	7,471	7,091
Total assets	38,587	38,610
Current liabilities:
Notes payable and short-term borrowings	218	1,106
Accounts payable	15,284	16,075
Other current liabilities	10,651	11,915
Total current liabilities	26,153	29,096
Long-term debt	10,796	6,386
Other non-current liabilities	4,556	4,778
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 980 and 1,092 shares issued and outstanding at October 31, 2022, and 2021 respectively)	10	11
Additional paid-in capital	1,172	1,060
Accumulated deficit	(4,413)	(2,461)
Accumulated other comprehensive income (loss)	313	(260)
Total stockholders’ deficit	(2,918)	(1,650)
Total liabilities and stockholders’ deficit	$ 38,587	$ 38,610